Eccentric Exercise Versus Neurodynamic Sliding Technique for Hamstring Flexibility and Lower-Limb Strength

October 31, 2026 updated by: Masood Khan, King Saud University

Eccentric Exercise Versus Neurodynamic Sliding Technique for Hamstring Flexibility and Lower-Limb Strength in Young Women With Hamstring Tightness: A Randomized Comparative Trial

This randomized comparative trial evaluated the effects of a six-week, supervised intervention comparing eccentric exercise to the neurodynamic sliding technique in 42 sedentary young women with hamstring tightness. Both interventions were completed without adverse events and produced significant improvements in hamstring flexibility (active knee extension) and lower-limb strength. Although the eccentric exercise group achieved significantly greater strength gains and greater flexibility improvements over time compared to the neurodynamic sliding group, the overall between-group differences in flexibility across time points were not statistically significant and were confounded by baseline imbalances. Consequently, while both approaches are effective for this population, eccentric exercise demonstrated greater overall benefits, though the between-group flexibility advantages warrant cautious interpretation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kerala
      • Calicut, Kerala, India
        • AWH Special College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Sedentary young women
  • 18 to 25 years
  • Absence of major metabolic comorbidity,
  • Active knee extension loss of at least 20 degrees,
  • Unilateral or bilateral hamstring tightness with full knee range of motion

Exclusion Criteria:

  • Prior injury,
  • Neurological dysfunction,
  • Spinal pathology,
  • Regular sports participation;
  • A history of musculotendinous hamstring injury;
  • A history of lumbar disc herniation;
  • Limited joint mobility of the hip, knee, or ankle,
  • Rheumatoid arthritis;
  • Anterior cruciate ligament tear without surgical correction;
  • Abnormal psychological conditions;
  • Radiating low back pain;
  • Congenital, traumatic, or acquired (pathological or infective) spinal conditions;
  • Malignancy;
  • Neck trauma.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The eccentric exercise group

In the eccentric exercise group the participants performed a TheraBand-assisted eccentric hamstring exercise three times weekly for a total duration of 6 weeks.

To perform hamstring eccentric exercises in supine with the lower extremities fully extended, a 1-meter TheraBand was wrapped around the foot and held in both hands. Participants actively flexed the hip while resisting eccentrically with the hamstrings for about 5 seconds, then slowly extended the hip.

Active Comparator: The neurodynamic sliding technique group

In the neurodynamic sliding technique group the participants performed a a seated slump-based neurodynamic sliding sequence three times weekly for a total duration of 6 weeks.

To perform the neurodynamic sliding technique, participants sat with a slouched posture and hands behind their backs, then alternated cervical extension with ankle dorsiflexion and knee extension, followed by cervical flexion with ankle plantarflexion and knee flexion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active Knee Extension Test
Time Frame: This outcome was measured before the initiation of the 6-week intervention and at the end of the 6-week intervention.

Participants lay supine with the hip and knee flexed to 90 degrees, actively extended the knee while maintaining hip position, and the popliteal angle was calculated as 180 degrees minus the measured knee extension angle, with lower values indicating greater flexibility. Normal Range for this outcome is 15 degrees - 25 degrees. Lower values indicate better outcome.

This outcome was measured before the initiation of the 6-week intervention and at the end of the 6-week intervention.
Lower-limb strength
Time Frame: This outcome was measured before the initiation of the 6-week intervention and at the end of the 6-week intervention.

Participants stood on the platform of Back-Leg-Chest dynamometer, with slight knee flexion, grasped the handle at knee level, and performed a maximal isometric lift for three seconds. Normal ranges: 220 to 330 lbs. Higher values indicate better outcome.

This outcome was measured before the initiation of the 6-week intervention and at the end of the 6-week intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kavitha Jayaraman, AWH Special College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 7, 2024

Primary Completion (Actual)

January 10, 2025

Study Completion (Actual)

February 18, 2025

Study Registration Dates

First Submitted

October 31, 2026

First Submitted That Met QC Criteria

October 31, 2026

First Posted (Actual)

November 5, 2026

Study Record Updates

Last Update Posted (Actual)

November 5, 2026

Last Update Submitted That Met QC Criteria

October 31, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe